Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
蜂皇胎胶囊
- Development stage
- Unknown
- Lead developer
- Guangzhou Nuojin Pharmaceutical
- Administration
- Oral
01
Overview
蜂皇胎胶囊 (Royal Jelly Capsules) is a nutraceutical dietary supplement developed and manufactured by Hangzhou Qianyuan Baoling Pharmaceutical (Hangzhou Baoling Group). Formulated as 0.2g oral capsules, the product contains royal jelly (蜂皇胎) as its primary active ingredient. It is specifically indicated for general maternal and infant nutritional support, serving as a health supplement to promote overall wellness during pregnancy and early development. As a natural nutritional product, it does not possess a documented pharmacological mechanism of action or specific biological targets.
- Brand names
- 蜂皇胎胶囊
- Other names
- Royal Jelly Capsules蜂皇胎胶囊 (0.2g)
Beyond the preview
Go deeper on 蜂皇胎胶囊.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 蜂皇胎胶囊.